FIELD: medicine, pharmaceutics.
SUBSTANCE: pharmaceutical dosed form contains a hard dispersion product of, at least, one active ingredient, dispersed in a polymer carrier composition. The polymer carrier composition contains a) vinylpyrrolidone homopolymer, in which, at least, 95 wt % of homopolymer have a molecular weight in the range from 1000 to 13000; and b) vinylpyrrolidone copolymer, which has an average molecular weight from 5000 to 1500000. The dosed form, preferably, is obtained by a melt extrusion method.
EFFECT: polymer carrier composition by the invention forms from the said polymers a homogeneous mixture which has only one vitrification temperature Tg, and has high ability to dissolve a medication.
13 cl, 5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION | 2007 |
|
RU2468788C2 |
| COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX | 2006 |
|
RU2423997C9 |
| THE METHOD OF OBTAINING A PHARMACEUTICAL COMPOSITION WITH TACROLIMUS (VARIANTS) AND A PHARMACEUTICAL COMPOSITION OBTAINED BY THESE METHODS | 2022 |
|
RU2792098C1 |
| PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
| PHARMACEUTICAL COMPOSITION FOR HIV INFECTION TREATMENT | 2016 |
|
RU2619840C1 |
| MEDICINAL DOSAGE FORM, WHICH CONTAINS 6'-FLUOR-(N-METHYL-OR N,N-DIMETHYL)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,b]INDOLE]-4-AMINE | 2011 |
|
RU2582390C2 |
| OBTAINING SOLID MEASURED FORMS USING CROSS-LINKED NON-THERMOPLASTIC CARRIER | 2003 |
|
RU2344809C2 |
| PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2809144C2 |
| ANTIRETROVIRAL COMBINATION | 2008 |
|
RU2531089C2 |
| METHODS OF TREATING HEPATITIS C | 2013 |
|
RU2665365C2 |
